We are live on ! Find out more
LIM

Lagoda Investment Management Portfolio holdings

AUM $162M
1-Year Est. Return 49.7%
This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+49.7%
3 Year Est. Return
+193.16%
5 Year Est. Return
+230.21%
10 Year Est. Return
+1,614.49%
AUM
$268M
AUM Growth
-$37.3M
Cap. Flow
-$25.3M
Cap. Flow %
-9.42%
Top 10 Hldgs %
74.08%
Holding
30
New
Increased
6
Reduced
15
Closed
2

Sector Composition

Rank Sector Weight
1 Healthcare 50.01%
2 Technology 18.25%
3 Communication Services 13.03%
4 Financials 11.54%
5 Materials 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
1
Novo Nordisk
NVO
$208B
$26.4M 9.83%
980,096
-9,092
-0.9% -$249K
REGN icon
2
Regeneron Pharmaceuticals
REGN
$78.5B
$25.4M 9.47%
72,738
-1,578
-2% -$608K
RNR icon
3
RenaissanceRe
RNR
$13.3B
$24.5M 9.13%
208,574
-1,364
-0.6% -$156K
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
$22.8M 8.52%
565,243
-19,296
-3% -$734K
DMRC icon
5
Digimarc Corp
DMRC
$147M
$19.3M 7.18%
602,450
-3,580
-0.6% -$102K
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.36T
$19M 7.07%
547,880
+1,900
+0.3% +$68.2K
PTC icon
7
PTC
PTC
$15.8B
$18.6M 6.94%
495,393
-2,592
-0.5% -$92.9K
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
$18.4M 6.86%
157,560
-1,922
-1% -$273K
SNMX
9
DELISTED
Senomyx, Inc.
SNMX
$12.2M 4.57%
4,452,428
+73,921
+2% +$198K
MACK
10
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$12.1M 4.51%
285,223
-10,615
-4% -$578K
PGEN icon
11
Precigen
PGEN
$2.24B
$11.6M 4.31%
474,153
-133,948
-22% -$3.8M
TTOO
12
DELISTED
T2 Biosystems, Inc
TTOO
$11.2M 4.18%
284
+70
+33% +$3.16M
UI icon
13
Ubiquiti
UI
$33.7B
$11.1M 4.12%
286,137
+5,711
+2% +$212K
BIDU icon
14
Baidu
BIDU
$37.7B
$8.09M 3.02%
49,005
+25,831
+111% +$4.54M
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$4.36T
$7.9M 2.95%
224,620
-80
-0% -$2.94K
MON
16
DELISTED
Monsanto Co
MON
$7.88M 2.94%
76,198
-129,779
-63% -$12.9M
VNRX icon
17
VolitionRx Ltd
VNRX
$8.65M
$5.11M 1.9%
81,064
+447
+0.6% +$30.8K
ESGR
18
DELISTED
Enstar Group
ESGR
$3.55M 1.32%
21,910
-953
-4% -$150K
MA icon
19
Mastercard
MA
$502B
$1.88M 0.7%
21,378
-682
-3% -$65.1K
BRK.A icon
20
Berkshire Hathaway Class A
BRK.A
$1.1T
$868K 0.32%
4
Y
21
DELISTED
Alleghany Corp
Y
$148K 0.06%
270
-35
-11% -$18.2K
XOM icon
22
ExxonMobil
XOM
$644B
$67K 0.03%
715
COP icon
23
ConocoPhillips
COP
$147B
$59K 0.02%
1,350
-115
-8% -$5.07K
PFE icon
24
Pfizer
PFE
$143B
$54K 0.02%
1,620
ABBV icon
25
AbbVie
ABBV
$443B
$30K 0.01%
491

Similar funds

Lagoda Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Lagoda Investment Management held 30 positions worth $268M, down 12% from $305M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Lagoda Investment Management withdrew a net $25.3M in Q2 2016, closing 2 positions and reducing 15 holdings. Its most notable exit was Corning, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 50% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Lagoda Investment Management added an estimated $4.54M to Baidu.

  • Lagoda Investment Management added most to Baidu in Q2 2016, an estimated $4.54M increase.
  • Lagoda Investment Management's biggest Q2 2016 reduction was Monsanto Co, cutting an estimated $12.9M.
  • Lagoda Investment Management fully exited Corning in Q2 2016, selling an estimated $13M.
  • Lagoda Investment Management's ten largest holdings make up 74% of its $268M portfolio in Q2 2016.
  • Lagoda Investment Management opened 0 new positions and closed 2 in Q2 2016.
  • Lagoda Investment Management's portfolio value fell 12% quarter-over-quarter to $268M.

Based on Lagoda Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.